Metagenomic insights into the effects of Chive seed flavonoid on intestinal fermentation, morphology, and microbiota composition in sheep
Frontiers in Microbiology · 13.06.2025 · 16
DOI: 10.3389/fmicb.2025.1590400 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 13.06.2025. Verfasst von Xujie Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Gansu Agricultural University, Lanzhou, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chive seed flavonoid (CSF) exhibits antioxidant, digestive, and immunomodulatory properties, yet their effects on ruminant intestinal development and microbial ecosystems remain underexplored. This study systematically evaluated CSF supplementation (0.25% of concentrate) on intestinal morphology, volatile fatty acids (VFAs) dynamics, and microbiota composition in 16 weaned Hu lambs (3 months; 19.57 ± 1.56 kg initial weight) using histomorphometry, VFA quantification, and full-length 16S rRNA sequencing. Animals were randomly allocated to a control (basal diet) or CSF-supplemented group (T), following a 7-day adaptation and 90-day experimental protocol. Key findings revealed: (1) The T group demonstrated increased jejunal and ileal villus length ( p < 0.05), elevated villus height-to-crypt depth ratio (V/C; p < 0.05), thickened muscular layers ( p < 0.05), and reduced crypt depth ( p < 0.05). (2) CSF supplementation significantly elevated acetate, propionate, butyrate, and total VFAs ( p < 0.05) in ileum, cecum, colon, and rectum, with notable jejunal propionate and total VFAs increases ( p < 0.05). (3) Upregulated expression of ileal and cecal genes ( IGF1 , CD81 , CTNNBL1 , SLC39A8 ) linked to tissue morphogenesis and VFAs absorption was observed in the T group ( p < 0.01). (4) Full-length 16S analysis demonstrated CSF-enhanced microbial diversity and selective enrichment of Cyanobacteriota , Bacillus , Acetobacterium , and Streptomyces [Linear Discriminant Analysis Effect Size (LEfSe) analysis]. Regional microbial shifts included Bacteroidota proliferation in the small intestine and rectum, Actinomycetota dominance in duodenum/cecum/colon, and ileal enrichment of Bacillota , Clostridium , and Streptomyces . KEGG pathway analysis confirmed CSF-driven enhancements in carbohydrate/energy metabolism, immune regulation, and intestinal barrier pathways ( p < 0.05). In conclusion, dietary supplementation with 0.25% CSF improved intestinal morphology, increased the production of VFAs, and optimized microbial composition, thereby promoting intestinal health in sheep. This study provides a theoretical basis for the application of CSF in promoting healthy production in sheep.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Animal Science and Technology, Gansu Agricultural University, Lanzhou, China.
- Gansu Key Laboratory of Animal Generational Physiology and Reproductive Regulation, Lanzhou, China.
Zitieren
APA
Li, X., Li, D., Wang, C., Li, Q., Nie, Y., Zhang, L., Xu, J., & Ma, Y. (2025). Metagenomic insights into the effects of Chive seed flavonoid on intestinal fermentation, morphology, and microbiota composition in sheep. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1590400
Vancouver
Li X, Li D, Wang C, Li Q, Nie Y, Zhang L, et al. Metagenomic insights into the effects of Chive seed flavonoid on intestinal fermentation, morphology, and microbiota composition in sheep. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1590400
BibTeX
@article{Li2025,
author = {Li, Xujie and Li, Dengpan and Wang, Chunhui and Li, Qiao and Nie, Yajing and Zhang, Liming and Xu, Jin and Ma, Youji},
title = {Metagenomic insights into the effects of Chive seed flavonoid on intestinal fermentation, morphology, and microbiota composition in sheep},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1590400}
}
EUVIMED